Abstract
AbstractBackgroundLimited data about chronic post-COVID neuropsychiatric complaints exist in the literature.AimOur study aims to delineate the phenotypes of chronic neuropsychiatric symptoms among adult subjects recovering from their first COVID that occurred more than one year ago. We also aim to explore the clinical and socioeconomic risk factors of having a high loading of chronic neuropsychiatric symptoms.MethodsWe recruited a post-COVID group who suffered from their first pre-Omicron COVID more than a year ago, and a control group who had never had COVID. The subjects completed app-based questionnaires on demographic, socioeconomic and health status, a COVID symptoms checklist, mental and sleep health measures, and neurocognitive tests.ResultsThe post-COVID group has a statistically significantly higher level of fatigue compared to the control group (p<0.001). Among the post-COVID group, the lack of any COVID vaccination before the first COVID and a higher level of material deprivation before the COVID pandemic predicts a higher load of chronic post-COVID neuropsychiatric symptoms. Partial correlation network analysis suggests that the chronic post-COVID neuropsychiatric symptoms can be clustered into two major (cognitive complaints -fatigue and anxiety-depression) and one minor (headache-dizziness) cluster. A higher level of material deprivation predicts a higher number of symptoms in both major clusters, but the lack of any COVID vaccination before the first COVID only predicts a higher number of symptoms in the cognitive complaints-fatigue cluster.ConclusionsOur result suggests heterogeneity among chronic post-COVID neuropsychiatric symptoms, which are associated with the complex interplay of biological and socioeconomic factors.
Publisher
Cold Spring Harbor Laboratory
Reference34 articles.
1. Nalbandian A , Sehgal K , Gupta A , Madhavan MV , McGroder C , Stevens JS , et al. Post-acute COVID-19 syndrome. Nat Med [Internet]. 2021 Apr [cited 2023 Sep 11];27(4):601–15. Available from: https://www.nature.com/articles/s41591-021-01283-z
2. Multisystem effects of COVID-19: a concise review for practitioners
3. Baillie JK , Lone NI , Jones S , Shaw A , Hairsine B , Kurasz C , et al. Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study. The Lancet Respiratory Medicine [Internet]. 2023 Sep 22 [cited 2023 Sep 26];0(0). Available from: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00262-X/fulltext
4. Davis HE , Assaf GS , McCorkell L , Wei H , Low RJ , Re’em Y , et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine [Internet]. 2021 Aug 1 [cited 2021 Aug 27];38. Available from: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00299-6/abstract
5. Taquet M , Sillett R , Zhu L , Mendel J , Camplisson I , Dercon Q , et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. The Lancet Psychiatry [Internet]. 2022 Oct 1 [cited 2023 Aug 14];9(10):815–27. Available from: https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(22)00260-7/fulltext